Skip to main content

Advertisement

Log in

Differential expression of microRNAs in postoperative radiotherapy sensitive and resistant patients with glioblastoma multiforme

  • Research Article
  • Published:
Tumor Biology

Abstract

Glioblastoma multiforme (GBM) is the most malignant primary brain tumor and more resistant to radiotherapy. However, hetero-radiosensitivity occurs in different patients. MicroRNAs (miRNAs) play important roles in the initiation and progression of a multitude of tumors. The study aims to examine the different microRNAs expression profiles of postoperative radiotherapy sensitive and resistant patients with GBM, to make an inquiry about their potential role and discover a certain set of radio-sensitivity markers. Three paired samples from six GBM patients who had only been treated with postoperative radiotherapy were selected, and then, they were divided into radiotherapy sensitive group and resistant group according to their overall survivals, local recurrence rates, and Karnofsky Performance Scale scores. Expression profiles of miRNAs in these two groups were determined by the method of microarray assay. Comparing with resistant patients, 13 miRNAs were significantly upregulated and 10 miRNAs were greatly downregulated in sensitive group. Among them, four miRNAs were validated by quantitative RT-PCR. The differentially expressed miRNAs and their putative target genes were revealed by bioformatic analysis to play a role in cell signaling, proliferation, aging, and death. High-enrichment pathway analysis identified that some classical pathways participated in numerous metabolic processes, especially in cell cycle regulation, such as mTOR, MAPK, TGF-beta, and PI3K-Akt signaling pathways. Our research will contribute to identifying clinical diagnostic markers and therapeutic targets in the treatment of GBM by postoperative radiotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Huang Z, Cheng L, Guryanova OA, Wu Q, Bao S. Cancer stem cells in glioblastoma–molecular signaling and therapeutic targeting. Protein & cell. 2010;1:638–55.

    Article  CAS  Google Scholar 

  2. Takebe N, Harris PJ, Warren RQ, Ivy SP. Targeting cancer stem cells by inhibiting wnt, notch, and hedgehog pathways. Nat Rev Clin Oncol. 2011;8:97–106.

    Article  CAS  PubMed  Google Scholar 

  3. Ohgaki H. Epidemiology of brain tumors. Methods Mol Biol. 2009;472:323–42.

    Article  CAS  PubMed  Google Scholar 

  4. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. European Organisation for R, Treatment of Cancer Brain T, Radiotherapy G, National Cancer Institute of Canada Clinical Trials G: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–96.

    Article  CAS  PubMed  Google Scholar 

  5. Gonzalez-Gomez P, Sanchez P, Mira H. Micrornas as regulators of neural stem cell-related pathways in glioblastoma multiforme. Mol Neurobiol. 2011;44:235–49.

    Article  CAS  PubMed  Google Scholar 

  6. Joki T, Carroll RS, Dunn IF, Zhang J, Abe T, Black PM. Assessment of alterations in gene expression in recurrent malignant glioma after radiotherapy using complementary deoxyribonucleic acid microarrays. Neurosurgery. 2001;48:195–201. discussion 201–192.

    CAS  PubMed  Google Scholar 

  7. Chaudhry MA, Sachdeva H, Omaruddin RA. Radiation-induced micro-RNA modulation in glioblastoma cells differing in DNA-repair pathways. DNA Cell Biol. 2010;29:553–61.

    Article  CAS  PubMed  Google Scholar 

  8. Novakova J, Slaby O, Vyzula R, Michalek J. Microrna involvement in glioblastoma pathogenesis. Biochem Biophys Res Commun. 2009;386:1–5.

    Article  CAS  PubMed  Google Scholar 

  9. Xiong J, Bing Z, Su Y, Deng D, Peng X. An integrated mrna and microrna expression signature for glioblastoma multiforme prognosis. PLoS One. 2014;9:e98419.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Zhang W, Zhang J, Yan W, You G, Bao Z, Li S, et al. Whole-genome microRNA expression profiling identifies a 5-microrna signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme. Cancer. 2013;119:814–24.

    Article  CAS  PubMed  Google Scholar 

  11. Cellini F, Morganti AG, Genovesi D, Silvestris N, Valentini V. Role of microRNA in response to ionizing radiations: Evidences and potential impact on clinical practice for radiotherapy. Molecules. 2014;19:5379–401.

    Article  PubMed  Google Scholar 

  12. Wang XC, Du LQ, Tian LL, Wu HL, Jiang XY, Zhang H, et al. Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer. Lung Cancer. 2011;72:92–9.

    Article  PubMed  Google Scholar 

  13. Teo MT, Landi D, Taylor CF, Elliott F, Vaslin L, Cox DG, et al. The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes. Carcinogenesis. 2012;33:581–6.

    Article  CAS  PubMed  Google Scholar 

  14. Liu S, Yin F, Zhang J, Wicha MS, Chang AE, Fan W, et al. Regulatory roles of miRNA in the human neural stem cell transformation to glioma stem cells. J Cell Biochem. 2014;115:1368–80.

    Article  CAS  PubMed  Google Scholar 

  15. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun. 2005;334:1351–8.

    Article  CAS  PubMed  Google Scholar 

  16. Niemoeller OM, Niyazi M, Corradini S, Zehentmayr F, Li M, Lauber K, et al. Microrna expression profiles in human cancer cells after ionizing radiation. Radiat Oncol. 2011;6:29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Kozomara A, Griffiths-Jones S. Mirbase: Annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014;42:D68–73.

    Article  CAS  PubMed  Google Scholar 

  18. Chen G, Zhu W, Shi D, Lv L, Zhang C, Liu P, et al. Microrna-181a sensitizes human malignant glioma u87mg cells to radiation by targeting bcl-2. Oncol Rep. 2010;23:997–1003.

    CAS  PubMed  Google Scholar 

  19. Ruan WK, Shi Y, Wang J. Expression of miR-129-5p in glioma and its effect on glycometabolism and growth of human glioma cells. Jiangsu Med J. 2013;39:48–54.

    Google Scholar 

Download references

Acknowledgments

This work was supported by the grants from the National Nature Science Foundation of China under Grant (No. 81301180, 31200633) and China Postdoctoral Science Foundation funded project under Grant (No. 2014M562665).

Authors’ contribution

Han-dong Wang and He-ming Wu were responsible for the conception and design of the study. Yong-Tang, You-wu Fan, Wu-ting Wei, and Yong Wu contributed to the samples acquisition. Mamatemin Tohti and Xiao-ke Hao were responsible for data analysis. He-ming Wu and Yue-bing Hu were responsible for the interpretation of findings and the drafting of the manuscript. All authors critically reviewed the content and approved the final version for publication.

Conflict of Interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Han-dong Wang.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary materials Fig 5

miRNA-target gene-pathway network analysis. Red round rectangle nodes represented miRNAs, grey circle nodes represented target genes and green triangle nodes represented enrichment pathways. Edges indicated the inhibitive effect of miRNAs on target genes. (JPEG 507 kb)

Supplementary materials Fig 6

(JPEG 928 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, Hm., Wang, Hd., Tang, Y. et al. Differential expression of microRNAs in postoperative radiotherapy sensitive and resistant patients with glioblastoma multiforme. Tumor Biol. 36, 4723–4730 (2015). https://doi.org/10.1007/s13277-015-3121-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-3121-z

Keywords

Navigation